These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21577272)

  • 61. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
    Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
    Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions.
    Grubb A; Mentz RJ
    Expert Rev Cardiovasc Ther; 2020 Feb; 18(2):85-101. PubMed ID: 32066285
    [No Abstract]   [Full Text] [Related]  

  • 64. Recent advances in antiarrhythmic drug treatment of atrial fibrillation.
    Polovina MM; Potpara TS
    Recent Pat Cardiovasc Drug Discov; 2013 Aug; 8(2):112-26. PubMed ID: 23795692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
    Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C
    Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-antiarrhythmic drugs to prevent atrial fibrillation.
    Moro C; Hernández-Madrid A; Matía R
    Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The WATCHMAN left atrial appendage closure device for atrial fibrillation.
    Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter.
    Banchs JE; Wolbrette DL; Samii SM; Penny-Peterson ED; Patel PP; Young SK; Gonzalez MD; Naccarelli GV
    J Interv Card Electrophysiol; 2008 Nov; 23(2):111-5. PubMed ID: 18688699
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation.
    Fujiki A; Sakamoto T; Iwamoto J; Nishida K; Nagasawa H; Mizumaki K; Inoue H
    Circ J; 2006 Sep; 70(9):1138-41. PubMed ID: 16936425
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological therapy for atrial fibrillation: current options and new agents.
    Viswanathan MN; Page RL
    Expert Opin Investig Drugs; 2009 Apr; 18(4):417-31. PubMed ID: 19278302
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control.
    Sherman DG
    Stroke; 2007 Feb; 38(2 Suppl):615-7. PubMed ID: 17261701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
    Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Atrial fibrillation.
    Aronow WS
    Heart Dis; 2002; 4(2):91-101. PubMed ID: 11975840
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
    Kirchhof P; Bax J; Blomstrom-Lundquist C; Calkins H; Camm AJ; Cappato R; Cosio F; Crijns H; Diener HC; Goette A; Israel CW; Kuck KH; Lip GY; Nattel S; Page RL; Ravens U; Schotten U; Steinbeck G; Vardas P; Waldo A; Wegscheider K; Willems S; Breithardt G
    Eur Heart J; 2009 Dec; 30(24):2969-77c. PubMed ID: 19535417
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.